Royal Marsden NHS Foundation Trust clinical trials
Royal Marsden NHS Foundation Trust is the lead sponsor of 3 current clinical trials in our Canada, Ireland and France registers. 2 are recruiting patients now. The most common phase is Phase 3. The drugs named most often in its trials are Anastrozole, Exemestane and Fulvestrant. The most-studied condition is Prostate Cancer.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Royal Marsden NHS Foundation Trust
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
NCT06638541 · ClinicalTrials.gov ↗ · Prostate Cancer
|
Not applicable | Recruiting | 2025-01 | Canada |
|
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
NCT04985266 · ClinicalTrials.gov ↗ · ER+ Breast Cancer, HER2-negative Breast Cancer
|
Phase 2 | Recruiting | 2022-03 | France |
|
Prostate Advances in Comparative Evidence
NCT01584258 · Prostate Cancer
|
Phase 3 | Active, closed | 2012-08 | Ireland, Canada |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Royal Marsden NHS Foundation Trust trials
5 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Royal Marsden NHS Foundation Trust trials
3 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Canada | 2 | 1 |
| Clinical trials in Ireland | 1 | 0 |
| Clinical trials in France | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Prostate Cancer
Sponsors with the most current trials registered for this condition.
Questions about Royal Marsden NHS Foundation Trust trials
How many clinical trials does Royal Marsden NHS Foundation Trust sponsor?
Royal Marsden NHS Foundation Trust is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Canada, Ireland and France registers, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are Royal Marsden NHS Foundation Trust trials recruiting?
Yes. 2 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Royal Marsden NHS Foundation Trust testing?
Its current trials name 5 drugs and biologicals as interventions. The most frequent are Anastrozole (1), Exemestane (1), Fulvestrant (1), Letrozole (1) and Tamoxifen (1). The number in brackets is how many of its trials name each drug.
Does Royal Marsden NHS Foundation Trust have clinical trials in Ireland?
Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.